Seraphim Space Investment Trust (LSE: SSIT) leans on ICEYE re-rating and SpaceX IPO tailwind to consolidate FTSE 250 entry
Read More Pharma Industry News Can Kelun-Biotech and Merck turn sac-TMT into the first ADC plus immunotherapy standard in front-line lung cancer? Merck needs life after Keytruda. Kelun-Biotech’s sac-TMT lung cancer data may show how the next oncology cycle takes shape. bySrinathMay 31, 2026